Frontiers in Clinical Drug Research - HIV
View SampleDownload Sample
To Avail the Discount Please Click Below.
DEAL OF THE DAY:   US $80US $10020%

Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - HIV

Volume 1

eBook: US $100 Special Offer (PDF + Printed Copy): US $191
Printed Copy: US $141
Library License: US $400
ISSN: 2468-0397 (Print)
ISSN: 2352-5916 (Online)
ISBN: 978-1-60805-897-6 (Print)
ISBN: 978-1-60805-896-9 (Online)
Year of Publication: 2015
DOI: 10.2174/97816080589691140101


Frontiers in Clinical Drug Research – HIV is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of acquired immune deficiency syndrome (AIDS) and other disorders associated with human immunodeficiency virus (HIV) infection. The scope of the eBook series covers a range of topics including the medicinal chemistry and pharmacology of natural and synthetic drugs employed in the treatment of AIDS (including HAART) and resulting complications, and the virology and immunological study of HIV and related viruses. Frontiers in Clinical Drug Research – HIV is a valuable resource for pharmaceutical scientists, clinicians and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in HIV/AIDS research.

The first volume of this series features 7 chapters that cover a variety of topics including:

  • - Antiretroviral drug development
  • - HIV-1 genomics
  • - HIV drug targets such as ribosomes and HIV Integrase
  • - HAART associated nephrotoxicity


- Pp. i-ii (2)
Download Free

List of Contributors

- Pp. iii-iv (2)
Download Free

Antiretroviral Drugs: Current Therapy, Recent Developments and Future Perspectives

- Pp. 3-57 (55)
Matthew Phillips, Jenny Svärd
View Abstract

New Developments for Anti-HIV Treatment

- Pp. 58-66 (9)
Liã Bárbara Arruda, Jorge Casseb
View Abstract

Drugs Targeting the -1 Ribosomal Frameshifting that Generates the Enzymes of the Human Immunodeficiency Virus

- Pp. 67-82 (16)
Léa Brakier-Gingras, Johanie Charbonneau, Benjamin L. Miller
View Abstract

Sensing of SNP in HIV-1 Genome Using Fluorescent Oligonucleotide Probes

- Pp. 83-122 (40)
Kira Astakhova
View Abstract

Next Generation Anti-HIV Agent 4’-Ethynylstavudine: From the Bench to the Clinic

- Pp. 123-184 (62)
Kazuhiro Haraguchi, Shingo Takeda, Yutaka Kubota, Hiroki Kumamoto, Hiromichi Tanaka, Takayuki Hamasaki, Masanori Baba, Elijah Paintsil, Yung-Chi Cheng, Yasuo Urata
View Abstract

HIV Integrase - Biology and Inhibitor Design

- Pp. 185-265 (81)
Victoria Hann, Mark Ashton
View Abstract

Nephrotoxicity Associated with HAART

- Pp. 266-286 (21)
Siddhartha Yedla, Parikshit T. Hameer, Naheed Ansari
View Abstract

Subject Index

- Pp. 287-292 (6)
Download Free


.Emerging Approaches to Tackle Neglected Diseases: From Molecule to End Product.
.COVID 19 – Monitoring with IoT Devices.
.Recent Advances in the Application of Marine Natural Products as Antimicrobial Agents.
.Recent Trends and The Future of Antimicrobial Agents - Part 2.